Literature DB >> 19585166

HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).

Oscar Fernández1, Alfredo R-Antigüedad, María Jesús Pinto-Medel, Mari Mar Mendibe, Nestor Acosta, Begoña Oliver, Miguel Guerrero, Marcos Papais-Alvarenga, Victoria Fernández-Sánchez, Laura Leyva.   

Abstract

Genetic susceptibility to multiple sclerosis (MS) is associated with genes of the major histocompatibility complex, particularly with the HLA DRB1*1501-DQA1*0102-DQB1*0602 haplotype in Caucasians. To investigate the association of DRB1, DQA1 and DQB1 alleles and haplotypes with MS in Biscay, Basque Country, northern Spain, we examined 197 patients and 200 regionally matched controls. High resolution HLA class II typing was performed by polymerase chain reaction followed by sequence-specific oligonucleotide probe hybridization. Several alleles were overrepresented in MS patients compared with those of controls: DRB1*0402, DRB1*1303, DRB1*1501, DQA1*0102, DQB1*0301, and DQB1*0602. DQB1*0602 was the only potentially predisposing allele for MS that withstood Bonferroni correction and maintained the association in a logistic regression model. On the other hand, several alleles showed lower frequencies in the MS group: DRB1*0101, DQA1*0101, DQB1*0303, and DQB1*0501, but only DRB1*0101 and DQB1*0303 maintained a negative association with the disease in the regression analysis. Three haplotypes were identified as potentially predisposing for MS in our population: DRB1*1501-DQA1*0102-DQB1*0602, DRB1*0402-DQA1*0301-DQB1*0302, and HLA-DRB1*013-DQA1*05-DQB1*0301. Additionally, three haplotypes associated with a lower risk for MS were identified, exhibiting DRB1*0101-DQA1*0101-DQB1*0501 the strongest negative association with MS [12% in controls vs. 3.8% in MS, Pc = 0.00047, OR = 0.290 (95% CI = 0.160–0.528)], and suggesting, therefore, a putative protective role for this haplotype in the population under study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19585166     DOI: 10.1007/s00415-009-5223-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  81 in total

1.  A full genome search in multiple sclerosis.

Authors:  G C Ebers; K Kukay; D E Bulman; A D Sadovnick; G Rice; C Anderson; H Armstrong; K Cousin; R B Bell; W Hader; D W Paty; S Hashimoto; J Oger; P Duquette; S Warren; T Gray; P O'Connor; A Nath; A Auty; L Metz; G Francis; J E Paulseth; T J Murray; W Pryse-Phillips; R Nelson; M Freedman; D Brunet; J P Bouchard; D Hinds; N Risch
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

2.  The T244I variant of the interleukin-7 receptor-alpha gene and multiple sclerosis.

Authors:  A Alcina; M Fedetz; D Ndagire; O Fernández; L Leyva; M Guerrero; C Arnal; C Delgado; F Matesanz
Journal:  Tissue Antigens       Date:  2008-08

3.  Molecular analysis of HLA class I (HLA-A and -B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type).

Authors:  T Ono; M R Zambenedetti; K Yamasaki; Y Kawano; N Kamikawaji; H Ito; M Sakurai; Y Nishimura; J Kira; I Kanazawa; T Sasazuki
Journal:  Tissue Antigens       Date:  1998-12

4.  HLA evidence for the lack of genetic heterogeneity in Basques.

Authors:  D Comas; F Calafell; E Mateu; A Pérez-Lezaun; J Bertranpetit
Journal:  Ann Hum Genet       Date:  1998-03       Impact factor: 1.670

5.  The role of the CD58 locus in multiple sclerosis.

Authors:  Philip L De Jager; Clare Baecher-Allan; Lisa M Maier; Ariel T Arthur; Linda Ottoboni; Lisa Barcellos; Jacob L McCauley; Stephen Sawcer; An Goris; Janna Saarela; Roman Yelensky; Alkes Price; Virpi Leppa; Nick Patterson; Paul I W de Bakker; Dong Tran; Cristin Aubin; Susan Pobywajlo; Elizabeth Rossin; Xinli Hu; Charles W Ashley; Edwin Choy; John D Rioux; Margaret A Pericak-Vance; Adrian Ivinson; David R Booth; Graeme J Stewart; Aarno Palotie; Leena Peltonen; Bénédicte Dubois; Jonathan L Haines; Howard L Weiner; Alastair Compston; Stephen L Hauser; Mark J Daly; David Reich; Jorge R Oksenberg; David A Hafler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

6.  DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.

Authors:  O Fernández; V Fernández; A Alonso; A Caballero; G Luque; M Bravo; A León; C Mayorga; L Leyva; E de Ramón
Journal:  J Neurol       Date:  2004-04       Impact factor: 4.849

7.  Ethnicity-dependent association of HLA DRB1-DQA1-DQB1 alleles in Brazilian multiple sclerosis patients.

Authors:  S V Alves-Leon; R Papais-Alvarenga; M Magalhães; M Alvarenga; L C S Thuler; O Fernández y Fernandez
Journal:  Acta Neurol Scand       Date:  2007-05       Impact factor: 3.209

8.  Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis.

Authors:  Frida Lundmark; Kristina Duvefelt; Ellen Iacobaeus; Ingrid Kockum; Erik Wallström; Mohsen Khademi; Annette Oturai; Lars P Ryder; Janna Saarela; Hanne F Harbo; Elisabeth G Celius; Hugh Salter; Tomas Olsson; Jan Hillert
Journal:  Nat Genet       Date:  2007-07-29       Impact factor: 38.330

9.  Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.

Authors:  J P Rubio; J Stankovich; J Field; N Tubridy; M Marriott; C Chapman; M Bahlo; D Perera; L J Johnson; B D Tait; M D Varney; T P Speed; B V Taylor; S J Foote; H Butzkueven; T J Kilpatrick
Journal:  Genes Immun       Date:  2008-07-24       Impact factor: 2.676

10.  HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.

Authors:  Boel Brynedal; Kristina Duvefelt; Gudrun Jonasdottir; Izaura M Roos; Eva Akesson; Juni Palmgren; Jan Hillert
Journal:  PLoS One       Date:  2007-07-25       Impact factor: 3.240

View more
  5 in total

Review 1.  Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Authors:  Kyle T Amber; Dedee F Murrell; Enno Schmidt; Pascal Joly; Luca Borradori
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 2.  Advances in multiple sclerosis research in 2009.

Authors:  Stefan Nessler; Wolfgang Brück
Journal:  J Neurol       Date:  2010-08-06       Impact factor: 4.849

3.  Tumor necrosis factor beta (TNF-β) NcoI polymorphism is associated with multiple sclerosis in Caucasian patients from Southern Brazil independently from HLA-DRB1.

Authors:  A P Kallaur; S R Oliveira; A N C Simão; E R D de Almeida; H K Morimoto; J Lopes; L M Pelegrino; W L C J de Pereira; Daniele Frizon Alfieri; R M Andrade; S D Borelli; M A E Watanabe; D R Kaimen-Maciel; E M V Reiche
Journal:  J Mol Neurosci       Date:  2014-04-04       Impact factor: 3.444

4.  Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.

Authors:  Yuri Nakamura; Takuya Matsushita; Shinya Sato; Masaaki Niino; Toshiyuki Fukazawa; Satoshi Yoshimura; Shin Hisahara; Noriko Isobe; Shun Shimohama; Mitsuru Watanabe; Kazuto Yoshida; Hideki Houzen; Yusei Miyazaki; Ryo Yamasaki; Seiji Kikuchi; Jun-Ichi Kira
Journal:  J Neuroinflammation       Date:  2016-09-06       Impact factor: 8.322

5.  Local genetic variation of inflammatory bowel disease in Basque population and its effect in risk prediction.

Authors:  Koldo Garcia-Etxebarria; Olga Merino; Adrián Gaite-Reguero; Pedro M Rodrigues; Amaia Herrarte; Ane Etxart; David Ellinghaus; Horacio Alonso-Galan; Andre Franke; Urko M Marigorta; Luis Bujanda; Mauro D'Amato
Journal:  Sci Rep       Date:  2022-03-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.